Resources
Home
/
Resources
-
Implementing the Analytical Method Lifecycle Approach (ICH Q14/Revision of ICH Q2)
Roundtable 2 Notes: AT Europe 2020
-
CMC Strategy Forum Japan 2021 Presenter Media Kit
Presenter Media Kit -
CMC Strategy Forum Japan 2021 Attendee Media Kit
Attendee Media Kit -
Life Cycle Approach for Specifications
CMC Summary Paper: CMC Strategy Forum Europe 2007
-
CE Data Processing - Success Stories and Needed Improvements
Roundtable 8 Notes: CE Pharm 2021
-
Role CE in Real Time Release and Sample Prep Automation
Roundtable 7 Notes: CE Pharm 2021
-
Dips, Peaks, and pI Shifts: Mitigating Pharmalyte Lot Variability Impacts on cIEF Profiles
Roundtable 6 Notes: CE Pharm 2021
-
CE/MS: Successes and Challenges in Biopharmaceutical Development
Roundtable 5 Notes: CE Pharm 2021
-
New CE Frontiers - AAV, Vaccine Applications, Opportunities and Limitations for CE in DNA/RNA Applications
Roundtable 4 Notes: CE Pharm 2021
-
Strategies and Challenges for Setting Specifications for MAM in Relation to Conventional CE Methods
Roundtable 3 Notes: CE Pharm 2021
-
New CE Modalities- How to Analyze Complex Biomolecules
Roundtable 2 Notes: CE Pharm 2021
-
CE Training Best Practices including Neutral Coated Capillaries Pros and Pitfalls: Going Beyond the mAb Separations
Roundtable 1 Notes: CE Pharm 2021
-
Validation
Roundtable 10 Notes: CE Pharm 2020
-
DOE and QbD
Roundtable 9 Notes: CE Pharm 2020
-
Can We Go Any Faster with CE Automation?
Roundtable 8 Notes: CE Pharm 2020
-
CE Method Lifecycle Management
Roundtable 7 Notes: CE Pharm 2020
-
Integration of Electropherograms
Roundtable 6 Notes: CE Pharm 2020
-
Collaborations and Instrumentation Development
Roundtable 5 Notes: CE Pharm 2020
-
Peak ID
Roundtable 4 Notes: CE Pharm 2020
-
New Modalities
Roundtable 3 Notes: CE Pharm 2020